LNSRLENSAR, Inc.
0.0×
Less likely than average to be bought by an AI rollup
Top 77% of the Russell 3000. How it works
Develops laser systems for cataract & astigmatism treatment.
What the score is built on · read from the 10-K by Jev, out of 10; tick marks high
- Services shareLow0/10How much of revenue is services rather than products or software. Weighs most.
- Labor intensityMiddling5/10How much of the cost is people doing the work.
- Recurring revenueLow2/10Subscriptions, contracts and repeat customers.
- Fragmented marketLow3/10Many small competitors a buyer could roll up.
- AI-rollup fitLow0/10Jev's overall read on fit for an AI rollup.
- Work AI could doHigh7/10Share of the work AI could plausibly do.
Other things in the 10-K that mattered in past deals
Not part of the score. How often companies whose 10-K read the same way went on to a sponsor buyout of a services business, against the average company (the tick).
- Not people-delivered servicesAway from one0.1× as oftenOf 6,700 companies scoring low on "people-delivered services", a sponsor buyout of a services business came 0.1× as often as average
- Not an AI-rollup targetAway from one0.4× as oftenOf 9,066 companies scoring low on "ai-rollup target", a sponsor buyout of a services business came 0.4× as often as average
Deal filings
| Filed | Form | Acquirer | Price | Premium |
|---|---|---|---|---|
| May 19, 2025 | DEFM14A | Alcon Research, LLC | $14.00 | 24% |
| May 7, 2025 | PREM14A | Alcon Research, LLC | $14.00 | 24% |
| Mar 24, 2025 | 8-K | Alcon Research, LLC | — | — |
Key numbers
- Revenue
- —
- Operating margin
- —
- EBITDA
- —
- Net debt / EBITDA
- —
Financials
No XBRL financials yet.